Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer, will present the Company’s Deciparticle™ nanomedicine platform at ...
Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...
Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical ...
QbD principles and strategic thinking can reduce the time required to optimize formulation. To help pharmaceutical and biotech companies improve their operations, FDA has been promoting the use of ...
Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...
Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit - the largest global meeting dedicated purely to LNPs. The official event guide is your ...
Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...
Quotient Sciences has announced the successful initiation of a clinical study evaluating a novel drug product developed using artificial intelligence (AI) - a landmark achievement highlighting the ...
Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results